Air and gas embolism is one of the most definitively established HBOT indications, recognized by Medicare, the FDA and every major hyperbaric and diving medicine authority as the treatment of choice. The evidence base reflects decades of clinical outcome data and mechanistic certainty rather than placebo-controlled trials — because withholding HBOT from an embolism patient to administer sham treatment is ethically indefensible.

Physical mechanism — the only treatment that addresses the root cause: The mechanism of HBOT in gas embolism is physiologically unambiguous. Boyle’s Law establishes that gas volume decreases proportionally with increasing pressure: at 2.8 ATA (the standard US Navy Treatment Table 6 pressure), gas bubble volume is compressed to approximately 36% of its surface-pressure size. This physical compression directly dissolves bubbles back into solution, restoring blood flow in occluded vessels. No medication, surgical intervention or other therapy achieves this. HBOT is the only treatment that addresses the primary pathological mechanism of gas embolism at its source.

Accelerated nitrogen washout: HBOT simultaneously creates a large inert gas partial pressure gradient: the patient breathes 100% oxygen while bubbles contain approximately 79% nitrogen. This oxygen/nitrogen gradient accelerates diffusion of nitrogen out of bubbles into surrounding tissue, further accelerating bubble resolution far beyond what physical compression alone achieves. The combination of physical Boyle’s Law compression and accelerated nitrogen elimination makes HBOT substantially more effective than normobaric high-flow oxygen, which achieves only the washout effect. [Leitch DR, Green RD. Aviat Space Environ Med. 1986;57(11):1088–1094. PMID: 3790369]

Moon et al. — outcomes review in arterial gas embolism: Richard Moon and colleagues at the Duke Center for Hyperbaric Medicine published the most comprehensive outcome analysis of HBOT in arterial gas embolism (AGE), documenting neurological recovery in the large majority of patients treated promptly. The analysis confirmed that time to treatment is the single strongest predictor of outcome: patients treated within hours achieved far better neurological recovery than those treated late or not at all. [Moon RE. Undersea Hyperb Med. 2014;41(2):135–145. PMID: 24892874]

Divers Alert Network registry data: The Divers Alert Network (DAN) maintains the world’s largest registry of diving injuries including arterial gas embolism and decompression illness. Across thousands of treated cases, DAN data confirms that prompt HBOT is the strongest predictor of full neurological recovery, and documents the dose-response relationship between delay to recompression and permanent neurological deficit. [Vann RD et al. Lancet. 2011;377(9760):153–164. PMID: 21211644]

Iatrogenic gas embolism: Arterial gas embolism also occurs as a complication of medical procedures including cardiac catheterization, lung biopsy, mechanical ventilation and cardiopulmonary bypass. Published case series document that HBOT achieves neurological recovery in the majority of patients with iatrogenic AGE when administered promptly, confirming that the treatment principle applies regardless of embolism source. [Muth CM, Shank ES. N Engl J Med. 2000;342(7):476–482. PMID: 10675429]